MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Report search

Report search

Perform another search

Search results for: Pharmacia
Within categories: Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology, Healthcare,
Search results Pages:
Found: 4 documents.

Pfizer Inc.: PharmaVitae Profile
Published by: Datamonitor - 7/22/2009 - (110  Pages)
View table of contents

Description
Introduction

This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfol...(more)

Purchase Options

Mega-Mergers: Executing Change in the Pharma Industry
Published by: Decision Resources - 6/5/2009 - (20  Pages)
View table of contents

Description
Introduction

If consolidation is so advantageous for boosting a pharma company to a new level of productivity, why has Pfizer engaged in not just one but three mega-mergers in the past ...(more)

Purchase Options

Mergers and Acquisitions in the Pharmaceuticals Sector
Published by: Urch Publishing - 4/1/2009 - (143  Pages)
View table of contents

Description
On 26th January 2009, Pfizer announced plans to acquire Wyeth for $68 billion. Pfizer’s CEO, Jeffrey B Kindler, insisted the deal would be different from the company’s earlier mega-deals i...(more)

Purchase Options

Effective Deal Making in Drug Delivery
Published by: PharmaVentures Ltd. - 2/1/2009 - (0  Pages)
View table of contents

Description
"Looming patent expiry a major force in driving valuation"

Drugs with annual sales totalling over US$86 B in 2007 are due to go off patent by 2012. Therefore, the application of novel drug del...(more)

Purchase Options

Pages:

Perform another search

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us